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In developed countries, cancer of the
oral cavity and pharynx is rare in indi-
viduals who do not smoke and do not
drink alcohol. Few studies, however,
have included large enough groups of
case and control subjects to provide use-
ful information on the effect of alcohol
consumption in the absence of tobacco
smoking and the effect of tobacco smok-
ing in the absence of alcohol consump-
tion (1).
A multicenter, population-based,
case–control study (2) included 49 male
and 53 female nonsmoking case subjects
from the United States. In that study,
males who were nonsmokers and heavy
drinkers (ø30 drinks per week) had an
odds ratio (OR) of 5.8 for cancer of the
oral cavity and pharynx, but there was a
weaker association for women because
of their lower consumption of alcohol. A
hospital-based U.S. study (3) of non-
smokers who had cancer of the oral cav-
ity included 73 male and 100 female
subjects. That study found that in non-
smoking men, there was a strong rela-
tionship between consumption of alco-
hol and cancer of the oral cavity and
pharynx, with an OR of 4.4 for men who
had seven drinks or more per day. In
females, however, the pattern was in-
consistent, but the OR was 2.6 for
women who had seven drinks or more
per day. In an Italian study (4) of cancer
of the oral cavity and pharynx that in-
cluded six male and 21 female non-
smoking case subjects, the OR was 2.2
for individuals who had 56 drinks or
more per week when compared with in-
dividuals who were nondrinkers or mod-
erate drinkers. In another Italian study
(5) that included 13 nonsmoking indi-
viduals who had oral cancer, no consis-
tent risk trend was observed.
Information on cancer of the oral
cavity and pharynx in lifelong nondrink-
ers is more scarce (6). An Italian case–
control study (4) that included 14 male
and five female case subjects who were
nondrinkers found that nondrinkers who
were heavy smokers of tobacco had a
statistically significant OR of 12.9 for
cancer of the oral cavity and pharynx. A
large U.S. study (2) provided data on the
risk of cancer of the oral cavity and
pharynx in smokers of tobacco who
were also nondrinkers or occasional
drinkers (<1 drink per week); the OR
reached 7.4 in males who were heavy
smokers, and the OR reached 2.2 in fe-
males who were heavy smokers.
In this brief communication, we re-
port results of a large study of cancer of
the oral cavity and pharynx that we con-
ducted in Italy (province of Pordenone
and Rome) and Switzerland (Vaud Can-
ton) during the period from 1992
through 1997. Overall, this study in-
cluded 754 case subjects with incident,
histologically confirmed cancer of the
oral cavity and pharynx and 1775 con-
trol subjects who were in the hospital for
acute non-neoplastic conditions that
were unrelated to alcohol consumption
or tobacco use. Sixty case subjects and
692 control subjects were ‘‘never smok-
ers,’’ and 32 case subjects and 224 con-
trol subjects were ‘‘never drinkers’’
(Table 1). These groups were the sub-
jects of the present communication.
Control subjects belonged to the follow-
ing diagnostic categories: traumas,
mostly fractures and sprains (28%);
other orthopedic disorders, such as low
back pain and disc disorders (26%);
acute surgical conditions (25%); eye
diseases (14%); and other miscellaneous
diseases, such as skin and dental condi-
tions (8%). About 5% of case and con-
trol subjects approached during their
hospital stay refused to be interviewed.
The questionnaire asked for informa-
tion on the following topics: sociodemo-
graphic characteristics, physical activity,
body size measurements at various ages, a
problem-oriented personal medical his-
tory, and a family history of cancer.
A validated food-frequency question-
naire was also administered. In the main
questionnaire, the section on smoking
habit included questions on smoking
status (‘‘never smoker,’’ ‘‘ex-smoker,’’
or ‘‘current smoker’’), number of ciga-
rettes and/or cigars habitually smoked
per day, grams of tobacco for pipe
smoking, age at which the individual
started smoking, duration of the habit,
and years since stopping for ‘‘ex-
smokers.’’ ‘‘Ever smokers’’ were sub-
jects who had smoked at least one ciga-
rette per day for at least 1 year. For
alcohol consumption, the weekly num-
ber of drinks of wine (125 mL), beer
(330 mL), grappa (30 mL; a typical Ital-
ian liquor), amari (30 mL), digestives
(30 mL), and spirits (30 mL) was ob-
tained from the study subjects. ‘‘Never
drinkers’’ were individuals who had ab-
stained from drinking any alcoholic bev-
erage throughout their life. ‘‘Ex-
smokers’’ and ‘‘ex-drinkers’’ were
individuals who had abstained from any
type of smoking or drinking for at least
12 months at the time of cancer diagno-
sis or interview (for control subjects).
ORs and the corresponding 95% con-
fidence intervals (CIs) were computed
with the use of unconditional logistic re-
gression analysis (7), including terms
for study center, sex, age, and amount of
education. All P values reported are
two-sided.
For nonsmokers who drank alcohol,
the OR was not increased by 35 drinks
or fewer per week but rose to 5.0 for
35–55 drinks per week and 5.3
for 56 drinks or more per week (Table
2). The trend in risk was highly statisti-
cally significant. When drinkers who
had 35 drinks or more per week were
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compared with nondrinkers, the OR
seemed to be more elevated in women
(OR 4 14.4; 95% CI 4 2.2–92.7) than
in men (OR 4 2.4; 95% CI 4 0.5–
12.1), but the risk estimates were not
statistically heterogeneous (Wald x12 4
1.23; P 4 .27).
For never drinkers who were current
smokers of fewer than 25 cigarettes per
day, the OR was 1.5; however, for never
drinkers who were heavy smokers of to-
bacco, the OR rose to 7.2. When current
smokers (any number of cigarettes)
were compared with never smokers, the
ORs were similar for men (OR 4 1.2;
95% CI 4 0.1–9.8) and women (OR 4
1.9; 95% CI 4 0.6–6.0).
This study thus confirms that there is
a statistically significant risk of cancer
of the oral cavity and pharynx associ-
ated with heavy alcohol intake in never
smokers and associated with heavy to-
bacco smoking in never drinkers. To-
bacco smoke contains a number of car-
cinogenic substances and comes in
direct contact with the oral and pharyn-
geal mucosa (8). Consequently, the in-
creased risk of cancer of the oral cavity
and pharynx associated with tobacco use
in never drinkers is not surprising.
The association with alcohol intake
in never smokers is more difficult to in-
terpret, because ethanol per se is not a
proven carcinogen in animal experi-
ments (1). For nonsmokers, there is a
positive association with alcohol use;
however, this does not imply per se that
alcohol is a complete carcinogen. The
oral cavity and pharynx, in fact, are ex-
posed to other carcinogens, including
those of dietary (9) or viral (10) origin,
and alcohol may enhance the adverse ef-
fect of other carcinogenic agents in non-
smokers. As suggested before (11,12),
women may be more vulnerable than
men to alcohol-induced carcinogenesis.
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Table 1. Distribution of nonsmoking and nondrinking case subjects with cancer of the oral cavity and pharynx and nonsmoking and nondrinking control
subjects by age, education, study center, and sex (1992–1997)
No. of nonsmoking subjects No. of nondrinking subjects
Male Female Male Female
Case Control Case Control Case Control Case Control
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ø12 7 96 10 27 4 34 7 22
Study center
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Total 20 346 40 346 10 79 22 145
Table 2. Odds ratio (OR) of cancer of the oral cavity and pharynx and 95% confidence interval (CI)
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No. of subjects
OR* 95% CICase Control
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2 trend 6.2; P 4 .01
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Smoking status‡
Never smokers 16 139 1†
Current smokers‡
<25 cigarettes/d 6 44 1.5 (0.5–4.6)
ø25 cigarettes/d 3 5 7.2 (1.1–46.6)
x1
2 trend 3.2; P 4 .07
Ex-smokers 7 33 2.2 (0.8–6.2)
*Estimates from logistic regression equations, including terms for study center, age, sex, and education.
†Reference category.
‡One control subject who smoked a pipe only and two control subjects who smoked an unknown
number of cigarettes are not included.
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